Erythropoietin Supports the Survival of Prostate Cancer, But Not Growth and Bone Metastasis

Erythropoietin (Epo) is used in clinical settings to enhance hematopoietic function and to improve the quality of life for patients undergoing chemotherapy by reducing fatigue and the need for transfusions. However, several meta-analyses have revealed that Epo treatments are associated with an incre...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Shiozawa, Yusuke, McGee, Samantha, Pienta, Michael J., McGregor, Natalie, Jung, Younghun, Yumoto, Kenji, Wang, Jingcheng, Berry, Janice E., Pienta, Kenneth J., Taichman, Russell S.
Формат: Artigo
Язык:Inglês
Опубликовано: 2013
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978144/
https://ncbi.nlm.nih.gov/pubmed/23696192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcb.24592
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы